These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8181926)

  • 1. Fatal fulminant hepatitis from cyproterone acetate.
    Hirsch D; Kovatz S; Bernheim J; Shenkman L
    Isr J Med Sci; 1994 Mar; 30(3):238-40. PubMed ID: 8181926
    [No Abstract]   [Full Text] [Related]  

  • 2. [Fatal sub-fulminant hepatitis caused by cyproterone acetate. A new case].
    Castellani P; Bernardini D; Renou C; Zamora C; Portal I; Gauthier A; Botta-Fridlund D
    Gastroenterol Clin Biol; 1996; 20(10):915-6. PubMed ID: 8991155
    [No Abstract]   [Full Text] [Related]  

  • 3. Fatal fulminant hepatic failure due to cyproterone acetate.
    Friedman G; Lamoureux E; Sherker AH
    Dig Dis Sci; 1999 Jul; 44(7):1362-3. PubMed ID: 10489919
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Fulminant liver failure with a fatal outcome due to flutamide].
    Fernández Peña CM; Morano Amado LE; Montes Santiago J; Fachal C
    Med Clin (Barc); 1997 Feb; 108(6):237-8. PubMed ID: 9102495
    [No Abstract]   [Full Text] [Related]  

  • 5. Acute hepatitis induced by cyproterone acetate.
    Giordano N; Nardi P; Santacroce C; Geraci S; Gennari C
    Ann Pharmacother; 2001 Sep; 35(9):1053-5. PubMed ID: 11573856
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fulminant hepatic failure associated with bicalutamide.
    Schellhammer PF
    Urology; 1997 Nov; 50(5):827. PubMed ID: 9372905
    [No Abstract]   [Full Text] [Related]  

  • 7. [Acute hepatic necrosis in a patient treated with cyproterone acetate].
    Lombardi A; Ferrazza P; Castaldi F; Covotta L; Tesoriere A; Urbano V; Midiri G
    G Chir; 1998 Apr; 19(4):161-3. PubMed ID: 9628065
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Fatal fulminant hepatitis in a chimpanzee (Pan troglodytes) receiving cyproterone acetate.
    Roe WD; Geschke K; Pease C
    J Zoo Wildl Med; 2009 Dec; 40(4):799-802. PubMed ID: 20063830
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Fatal acute liver failure induced by cyproterone acetate: A new case.
    Nour E; Mehdi K; Hanene J; Hammami A; Ben Slama A; Ali J
    Presse Med; 2017 Dec; 46(12 Pt 1):1231-1232. PubMed ID: 29129412
    [No Abstract]   [Full Text] [Related]  

  • 10. Fulminant hepatitis due to cyproterone acetate.
    Lévesque H; Trivalle C; Manchon ND; Vinel JP; Moore N; Hémet J; Courtois H; Bercoff E; Bourreille J
    Lancet; 1989 Jan; 1(8631):215-6. PubMed ID: 2563116
    [No Abstract]   [Full Text] [Related]  

  • 11. Fatal acute tumor lysis syndrome, hepatic encephalopathy and flare phenomenon following combined androgen blockade.
    Tanvetyanon T; Choudhury AM
    J Urol; 2004 Apr; 171(4):1627. PubMed ID: 15017238
    [No Abstract]   [Full Text] [Related]  

  • 12. Treatment of prostatic cancer with cyproterone acetate as monotherapy.
    Beurton D; Grall J; Davody P; Cukier J
    Prog Clin Biol Res; 1987; 243A():369-77. PubMed ID: 2958861
    [No Abstract]   [Full Text] [Related]  

  • 13. [Fatal hepatitis caused by cyproterone acetate].
    Bressollette L; Dubois A; Carlhant D; Morand C; Mottier D; Riche C
    Therapie; 1994; 49(2):153. PubMed ID: 7817350
    [No Abstract]   [Full Text] [Related]  

  • 14. [Fatal subfulminant hepatitis caused by cyproterone acetate].
    Antoni M; Bourlière M; Toullec J; Maillot A; Botta-Fridlund D; Gauthier A
    Gastroenterol Clin Biol; 1991; 15(10):772-3. PubMed ID: 1840042
    [No Abstract]   [Full Text] [Related]  

  • 15. Severe hepatocellular dysfunction following cyproterone acetate therapy.
    Parys BT; Hamid S; Thomson RG
    Br J Urol; 1991 Mar; 67(3):312-3. PubMed ID: 1827039
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Fulminant hepatic failure associated with bicalutamide.
    Dawson LA; Chow E; Morton G
    Urology; 1997 Feb; 49(2):283-4. PubMed ID: 9037299
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cyproterone acetate: hepatotoxicity and prostatic cancer treatment.
    Roila F; Crinò L; Carloni G; Natalini G
    Ann Oncol; 1993 Sep; 4(8):701. PubMed ID: 8241005
    [No Abstract]   [Full Text] [Related]  

  • 18. [Cyproterone acetate (Androcur-depo) in the treatment of inoperable prostatic cancer].
    Stepanov VN; Goriunov VG; Chechenin MG; Sivkov AV; Gubdurakhmanov II
    Urol Nefrol (Mosk); 1995; (6):33-6. PubMed ID: 8686122
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Severe hepatitis and liver failure induced by cyproterone acetate.
    Murphy BJ; Collins BJ
    Aust N Z J Med; 1996 Oct; 26(5):724. PubMed ID: 8958378
    [No Abstract]   [Full Text] [Related]  

  • 20. [Hepatic encephalopathy induced by flutamide administered for the treatment of prostatic cancer].
    Patel H; Rhee E; Zimmern PE
    J Urol (Paris); 1996; 102(3):123-5. PubMed ID: 9091557
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.